BioCentury
ARTICLE | Company News

GlaxoSmithKline, Aspen deal

September 19, 2016 7:00 AM UTC

The partners terminated a 2009 deal to co-commercialize their product portfolios in sub-Saharan Africa, excluding South Africa, where Aspen received marketing rights to GlaxoSmithKline’s products. The...